Cargando…
IGHG1 upregulation promoted gastric cancer malignancy via AKT/GSK-3β/β-Catenin pathway
BACKGROUND: Despite current advances in gastric cancer treatment, disease metastasis and chemo-resistance remain as major hurdles against better overall prognosis. Previous studies indicated that IGHG1 as well as -Catenin serve as important regulators of tumor cellular malignancy. Therefore, underst...
Autores principales: | Li, Xinyu, Chen, Wen, Yang, Chunkang, Huang, Yisen, Jia, Jing, Xu, Rongyu, Guan, Shen, Ma, Ruijun, Yang, Haitao, Xie, Lifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314571/ https://www.ncbi.nlm.nih.gov/pubmed/34315496 http://dx.doi.org/10.1186/s12935-021-02098-1 |
Ejemplares similares
-
miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma
por: Yang, Nanmu, et al.
Publicado: (2019) -
miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling
por: Chen, Gang, et al.
Publicado: (2017) -
Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy
por: Liu, Yeying, et al.
Publicado: (2019) -
Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway
por: Zhou, Yongping, et al.
Publicado: (2020) -
Girdin acts as an oncogene in gastric cancer by regulating AKT/GSK3β/β-catenin signaling
por: Wang, Yun, et al.
Publicado: (2023)